H1N1 influenza split virion vaccine, inactivated (Jiangsu Yanshen)

甲型H1N1流感病毒裂解疫苗（江苏延申）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH1N1 influenza split virion vaccine, inactivated (Jiangsu Yanshen)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaInfluenza, Human

Original Approved Country/TerritoryMainland China

Original Approved Date2009/09/18

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaWithdrawn

Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJiangsu Ealong Biology Technology Co Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB02